A federal deadline ending the sale of compounded semaglutide (Ozempic, Wegovy) is now in effect after a similar one for ...

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients ...

The following is a summary of “Investigating socioeconomic disparities in prescribing new diabetes medications in individuals ...

Metformin, a drug used as a first-line treatment for type 2 diabetes, has been associated with a 30% lower risk of death, ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

Current labeling advises matching the inhaled insulin units to the injected mealtime dose of rapid-acting insulin analog.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are designed to lower high blood glucose levels typical in T2DM, and work by inhibiting the sodium-glucose transport ...

Common diabetes drugs tied to brain health The research, published in JAMA Neurology , draws on Medicare data from tens of thousands of older adults diagnosed with Type 2 diabetes.

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

"Currently, Medicare covers these drugs only under specific circumstances, such as for diabetes or heightened heart risk," he wrote. "And Medicaid coverage is even more limited." Fetterman added ...